Ormsby M, Logan M, Johnson S, McIntosh A, Fallata G, Papadopoulou R
EBioMedicine. 2019; 43:325-332.
PMID: 31036531
PMC: 6557746.
DOI: 10.1016/j.ebiom.2019.03.071.
Kim H, Li H, Collins J, Ingber D
Proc Natl Acad Sci U S A. 2015; 113(1):E7-15.
PMID: 26668389
PMC: 4711860.
DOI: 10.1073/pnas.1522193112.
Ahmed A, Kadaru A, Omer I, Musa A, Enan K, El Khidir I
J Clin Exp Hepatol. 2015; 4(4):279-86.
PMID: 25755574
PMC: 4298631.
DOI: 10.1016/j.jceh.2014.08.003.
Shay J, Imtiyaz H, Sivanand S, Durham A, Skuli N, Hsu S
Carcinogenesis. 2014; 35(5):1067-77.
PMID: 24408928
PMC: 4004204.
DOI: 10.1093/carcin/bgu004.
Yi X, Zeng C, Liu H, Chen X, Zhang P, Yun B
PLoS One. 2013; 8(12):e81269.
PMID: 24324683
PMC: 3852499.
DOI: 10.1371/journal.pone.0081269.
Reduced inflammation and lymphoid tissue immunopathology in rhesus macaques receiving anti-tumor necrosis factor treatment during primary simian immunodeficiency virus infection.
Tabb B, Morcock D, Trubey C, Quinones O, Hao X, Smedley J
J Infect Dis. 2012; 207(6):880-92.
PMID: 23087435
PMC: 3571439.
DOI: 10.1093/infdis/jis643.
Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.
Glasser A, Boudeau J, Barnich N, Perruchot M, Colombel J, Darfeuille-Michaud A
Infect Immun. 2001; 69(9):5529-37.
PMID: 11500426
PMC: 98666.
DOI: 10.1128/IAI.69.9.5529-5537.2001.
Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease.
Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S
J Clin Immunol. 1997; 17(2):154-9.
PMID: 9083891
DOI: 10.1023/a:1027378532003.
Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.
Gardiner K, Crockard A, Halliday M, Rowlands B
Gut. 1994; 35(4):511-6.
PMID: 8174990
PMC: 1374801.
DOI: 10.1136/gut.35.4.511.
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease.
Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T
Clin Exp Immunol. 1994; 96(3):432-6.
PMID: 8004812
PMC: 1534558.
DOI: 10.1111/j.1365-2249.1994.tb06047.x.
Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80.
Lee S, Starkey P, Gordon S
J Exp Med. 1985; 161(3):475-89.
PMID: 3973536
PMC: 2187577.
DOI: 10.1084/jem.161.3.475.
Interleukin 1 in Crohn's disease.
Satsangi J, Wolstencroft R, Cason J, Ainley C, Dumonde D, Thompson R
Clin Exp Immunol. 1987; 67(3):594-605.
PMID: 3496997
PMC: 1542614.
The aetiology of Crohn's disease.
Tytgat G, Mulder C
Int J Colorectal Dis. 1986; 1(3):188-92.
PMID: 3302083
DOI: 10.1007/BF01648449.
Problems of bacterial infection in patients with liver disease.
Wyke R
Gut. 1987; 28(5):623-41.
PMID: 3297941
PMC: 1432873.
DOI: 10.1136/gut.28.5.623.
Macrophages and mast cells in dystrophic masseter muscle: a light and electron microscopic study.
Kirkeby S, Mikkelsen H
Br J Exp Pathol. 1988; 69(4):597-603.
PMID: 3179201
PMC: 2013227.
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells.
Goerig M, Habenicht A, Heitz R, Zeh W, Katus H, KOMMERELL B
J Clin Invest. 1987; 79(3):903-11.
PMID: 3102559
PMC: 424233.
DOI: 10.1172/JCI112900.
Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage.
Chuang W, Liu H, Chang W, Chen S, Hsieh M, Wang L
Dig Dis Sci. 1991; 36(3):299-302.
PMID: 1995265
DOI: 10.1007/BF01318200.
Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.
G Williams J
Ann R Coll Surg Engl. 1990; 72(4):253-62.
PMID: 1974406
PMC: 2499228.
Infections.
Rolando N, Wyke R
Gut. 1991; Suppl:S25-8.
PMID: 1916466
PMC: 1405208.
DOI: 10.1136/gut.32.suppl.s25.